Company Filing History:
1 out of 15,543 
1 out of 2 
1 out of 832,966 Years Active: 2000-2004
Title: Lynne Allison McInnes: Advancing Bipolar Mood Disorder Research through Innovative Patents
Introduction:
Lynne Allison McInnes, based in San Francisco, CA, is a highly accomplished inventor and researcher specializing in the field of bipolar mood disorder. With an impressive portfolio of patents and extensive experience in renowned institutions such as the University of California and The University of Costa Rica, McInnes has made significant contributions to the field. This article delves into McInnes' latest patents, career highlights, collaborations, and their ongoing dedication to advancing bipolar mood disorder research.
Latest Patents:
McInnes has obtained two groundbreaking patents that analyze genetic markers associated with bipolar mood disorder. The first patent revolves around methods for treating bipolar mood disorder associated with markers on chromosome 18p. McInnes' research has identified a susceptibility gene for bipolar mood disorder that resides within the terminal 5 cM region of the short arm of chromosome 18. This discovery has paved the way for advanced diagnostic methods and personalized treatments.
The second patent focuses on methods for treating bipolar mood disorder associated with markers on chromosome 18q. This patent highlights the presence of a susceptibility gene located in the 18q22-q23 region of the long arm of chromosome 18. McInnes' work involving genetic markers and linkage analysis has enabled accurate genotype diagnoses, confirmation of phenotypic diagnoses, and tailored treatment strategies for individuals with specific genotypic subtypes of bipolar mood disorder.
Career Highlights:
Throughout their career, McInnes has dedicated themselves to unraveling the complexities of bipolar mood disorder to ultimately improve treatment options and enhance the lives of affected individuals. Their pioneering research has provided a deeper understanding of the genetic markers associated with the disorder, enabling novel methods for diagnosis and personalized treatment.
Collaborations:
McInnes has collaborated with esteemed researchers in the field of bipolar mood disorder such as Nelson B Freimer and Lodewijk Sandkuijl. Through these collaborations, McInnes has strengthened their research and contributed to a collaborative environment that fosters innovation and knowledge exchange.
Conclusion:
Lynne Allison McInnes' work in the field of bipolar mood disorder has been instrumental in advancing our understanding of the genetic basis of this complex disorder. With their latest patents, McInnes has provided valuable insights into the genetic markers associated with bipolar mood disorder on chromosome 18p and 18q. Their dedication to research and collaboration with esteemed colleagues has propelled the field forward, opening doors to enhanced diagnoses and personalized treatment options. McInnes continues to inspire and make significant contributions to the field of bipolar mood disorder, offering hope for those affected by this challenging condition.